Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03012321 |
|---|---|
| Brief Title: | Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects |
| First Submitted : | January 3, 2017 |
| First Submitted that Met QC Criteria : | January 4, 2017 |
| First Posted : | January 6, 2017 (Estimate) |
| Last Update Submitted that Met QC Criteria : | March 1, 2021 |
| Last Update Posted : | March 3, 2021 |